20 Hrs
Source:
Financial Times
Pfizer Faces Challenges Post-Covid
Pfizer's decreasing vaccine revenues and concerns over potential overpayment for new drugs are increasing pressure on CEO Albert Bourla.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)